NJ Consumers Urge Court To Revive Accutane Litigation

By Bill Wichert (March 7, 2017, 10:01 PM EST) -- Counsel for consumers urged a New Jersey appellate panel Tuesday to revive consolidated litigation alleging that Hoffmann-La Roche Ltd.'s acne medication Accutane caused their clients to develop Crohn's disease, arguing that a trial court overstepped its authority in barring their expert testimony and dismissing more than 2,000 cases.

Plaintiffs' attorneys called on the panel to reverse the 2015 rulings, saying the court should have found that the consumers' experts relied on evidence of the kind generally followed by comparable experts instead of reaching its own conclusions about the evidence — findings that the lawyers said should have been left to jurors...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!